Genetically Modified Blood Could Be The New Cure For Cancers

Posted: Feb 16 2016, 8:48am CST | by , in News | Latest Science News


T-cell immunotherapy
Photo credit: Mail Online

T-cell immunotherapy could be the new cure for cancers, and this involves genetically modified blood which is re-infused into the patient to attack cancer cells in a treatment that is known as “living drug,” Mail Online reports. This treatment was first applied to British baby Layla Richards last year and it proved very successful, going on to win worldwide acclaim.

This treatment does not only cure cancer in a sense, it also effectively stops it from ever returning – constantly looking for cancer cells to destroy. The treatment is developed from an individual’s own body cells, and it works like a vaccine for up to 14 years in one study, and it totally cured 94% of terminally ill patients in another study.

This immunotherapy treatment has proved effective in healing leukemia among other sol-called liquid cancers and not only in solid tumors, making it a promising solution to curing cancers.

T-cells are extracted from an individual’s blood and then genetically modified to identify and attack cancer cells, after they are grown into million numbers and then infused back into the patient to enable the reengineered T-cells hunt down and destroy cancer cells.

The San Raffaele Scientific Institute in Milan recorded many of the successes seen so far, with 10 patients given infusions of T-cells which worked effectively to restore the health of the patients.

Dr. Chiara Bonini, one of the researchers praised the procedure, telling the American Association for the Advancement of Science that T-cells survived for 14 years in a few patients and that the cells could last for life in many patients.

“T-cells are a living drug and they have the potential to persist in our body for whole lives,” said Dr. Bonini. “Our findings have profound implications for the design of T-cell-based immunotherapies.”

Another expert on immune system and immune therapy, Professor Daniel Davis of Manchester University hailed the study “the implication is that infusing genetically-modified versions of these particular T-cells could provide a long-lasting immune response. Immunotherapy has great potential to revolutionize cancer treatments and this study shows which type of T-cells might be especially useful to manipulate.”

You May Like


The Author

<a href="/latest_stories/all/all/52" rel="author">Charles I. Omedo</a>
Charles is covering the latest discoveries in science and health as well as new developments in technology. He is the Chief Editor or Intel-News.




Leave a Comment

Share this Story

Follow Us
Follow I4U News on Twitter
Follow I4U News on Facebook

You Also Like


Read the Latest from I4U News